chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chills and restlessness starting evening of 9/10.   At 3am on 9/11 woke up suddenly with vertigo which lasted 7 hours.   Meclizine at 6am.  Temp was 100 despite round the clock Tylenol.   Severe fatigue, nausea, inability to eat for two days.   Seen in Urgent Care at 10:30am on 9/11.   Vertigo was subsiding and neuro exam was normal.  Received 500 cc IVF for mild dehydration.,    Continued with Tachycardia to 106 (normal 57 to 65)  and hypertension  170/ 98.  Tachycardia and hypertension started to subside by 6pm on 9/11.    Slept 13 to 14 hours.   On 9/12 no vertigo but with significant brain fog
A day after the vaccine I got red hives all over my thighs that eventually went away 2 days later. The day after this subsided I started to get extremely itchy rashes on my neck that would come and go.  This has continued to occur. Exactly one week after the vaccine was given my lips began to swell up and become numb, again this went away with time.
Discharge Provider:  DO; Primary Care Provider: MD; Admission Date: 2/1/2023; Discharge Date: 2/6/2023.  PRESENTING PROBLEM: Shortness of breath [R06.02] Acute respiratory failure due to COVID-19 (HCC) [U07.1, J96.00]  HOSPITAL COURSE: The patient is an 83-year-old female with history of PE, hypertension, CKD stage 3, diastolic heart failure, chronic obstructive pulmonary disease, and chronic back pain who presented to the emergency department with complaint of sore throat, malaise, cough, and shortness of breath.  On arrival to the emergency department she was hypoxic to 83% on room air requiring 2 L of oxygen via nasal cannula.  COVID was positive.  Chest x-ray showed mild pulmonary vascular congestion.  She was started on IV antibiotics for pneumonia and IV Solu-Medrol.  The patient was admitted to the hospitalist group.  Further antibiotics were held.  She completed three day course of remdesivir and a few days of oral dexamethasone before weaning to room air. She developed diarrhea which was treated with Imodium. Diarrhea improved and manageable on day of discharge.  PT/OT evaluated the patient and recommended home with home healthcare.  She showed clinical improvement and discharged home in stable condition on 2/6/2023.
The patient was admitted with worsening valvular heart disease. She appears to have nonbacterial thrombotic endocarditis. This, in turn, MAY be due to anticardiolpin Ab/antiphospolipid syndrome
This spontaneous report as received from a medical assistant refers to a patient of an unknown age and gender who on 03-APR-2015 was vaccinated with a dose of oral, ROTATEQ (lot # K016313) (expiration date, dose and route not reported) that was 12 hours in temperature excursion. No adverse effects had been observed or reported. This is one of several reports received from the same source. Additional information has been requested.
Right big toe pain; Heart palpitations; Tightness in the chest; Blood pressure increased; Gets out of breath quicker when walking; This is a spontaneous report from a contactable consumer (patient). An 78 year old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection and Batch/Lot number was not reported) via an unspecified route of administration on 27Jul2021 (age at vaccination: 78 year old) as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient was received her first dose of the Pfizer-Biontech Covid19 vaccine 27Jul2021. The patient experiencing "heart palpitations, tightness in the chest, right big toe pain, blood pressure increased, and gets out of breath quicker when walking in 2021". Her HCP did an EKG and chest X-ray in 2021 with unknown results. He has prescribed prednisone, which she would still be on during her second dose scheduled for 17Aug2021. She reported that she has been on prednisone from the toe situation, and now HCP put her on prednisone again saying she might have asthma, which she have never had asthma problems." She was very nervous about getting the second dose, stating "With the vaccine you can still get the virus or be a carrier and you still have to wear a mask. So that's kind of a scary thing, plus its not been FDA approved yet. The patient was really scared, at her age and she keep hearing horror stories everywhere that somebody'll get the second dose and die." She's looking for guidance on how to proceed saying "she don't know which way to go with it". The event right big toe pain was considered as serious (medically significant) by health authority. The outcome of the event was unknown.  The lot number for the vaccine BNT162B2 was not provided and will be requested during follow up.
Patient was only administered the grey vial (liquid portion) of the Meningococcal Conjugate (Menveo by GSK).  The grey vial with the C, W, and Y conjugates was not mixed with the orange vial (powder) which contains the Men A conjugate.
low grade fever,  full body achiness, headache, unable to sleep well  for 22 hours
Flu like Symptoms, progressing to acute renal failure as a result of (HUS), only blood and urine samples cultured any trace of E. coli, stool samples have not grown any E. coli bacteria. Test POS for Influenza A.
No pain or problems at injection site on 1/28/21. On  2/5/21 red itchy 3x5 patch appeared around the injection site (COVID arm). Not painful. No swelling.  On 2/5, approximately 2 hours before COVID rash appeared on right arm, the arm was in the sun (sleeveless)  for approximately 10-15 minutes. No tan/sunburn.  Patient treated arm (at home) with ice and benadryl ointment but no immediate change observed. The rash did not fade until 2/12, but still remained itchy and same size. On 2/13 redness fading more, but site still itchy and same size. Patient reported the COVID arm side effect to Moderna on 2/8/21 and was given a code number.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29-year-old male patient received BNT162b2 (BNT162B2), on 20Dec2021 as dose 3 (booster), single (Lot number: 331308A) at the age of 28 years, in right arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 17Mar2021 as dose 1, single (Lot number: 006P21A), in right arm and on 20Apr2021 as dose 2, single (Lot number: 039B21A), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Interchange of vaccine products", start date: 20Dec2021, stop date: 20Dec2021. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (05Jul2022) Positive, notes: Tested positive again for COVID 11 days after ending Paxlovid treatment regimen. Therapeutic measures were taken as a result of drug ineffective, covid-19.
I am the epidemiologist reporting on behalf of 83 year-old male patient.  Patient received one dose of the Pfizer vaccine on 3/19/2021, according to immunization records.  The patient passed away at home on 3/21/2021 (2 days post first dose). The death certificate lists ?Sudden Cardiac Death? as the immediate cause of death secondary to non-ischemic cardiomyopathy (18 months). No additional information regarding underlying conditions that may have contributed to this death is available.
Information has been received from a licensed practical nurse concerning a female patient with sulfonamide allergy who on an unspecified date was vaccinated with HPV rL1 6 11 16 18 VLP vaccine (yeast). Subsequently the patient experienced a fever for four days. Unspecified medical attention was sought. No further details were provided. Additional information has been requested. This is a follow-up to report (s).  Information has been received from a physician concerning his 19 year old daughter with a sulfonamide allergy and no other pertinent medical history reported.  In August 2006, the patient was vaccinated with the first dose of GARDASIL by another health care professional.  Concomitant therapy included EFFEXOR.  In approximately August 2006, "about 4 days after being vaccinated", the patient developed a primary herpetic gingivostomatitis on her lips.  The patient sought unspecified medical attention.  All symptoms had resolved.  At the time of this report.  The patient had recovered from the event (date unknown).  Additional information has been requested.
Patient symptoms include extreme dizziness, nausea, racing and irregular heart rate lasting for about 3 hours, burning chest pain while breathing, a fever that started 8 hours after vaccine and last for about 2 days. Pt also reports very sharp pain around the injection site that was ongoing for several days following injection. Fever broke with use of Tylenol.  Treatment currently ongoing and monitoring patients.
Patient complained of feeling faint, hot, dizziness and nausea. Patient felt clammy to the touch not hot. Emergency medical support was called and took over patient care.
This patient received an MMR vaccination at 4:15 PM at about 4:50 PM, the patient returned to the clinic with face swollen, hoarse, complained of "some" chest pain. She had left periorbital edema, right cheek / jaw swollen, injection site raised, swollen, and warm to touch. Immediately to the ER, given Benadryl. She was admitted for observation on 03/22/01, status improved.
Chills; Body aches; Fever; 2nd dose administered >35 days after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose administered >35 days after 1st dose), CHILLS (Chills), MYALGIA (Body aches) and PYREXIA (Fever) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 028A21A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included VITAMIN C [ASCORBIC ACID] for an unknown indication.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose administered >35 days after 1st dose). On 06-Apr-2021, the patient experienced CHILLS (Chills), MYALGIA (Body aches) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) in April 2021 for Adverse event, at an unspecified dose and frequency. On 05-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose administered >35 days after 1st dose) had resolved. On 07-Apr-2021, CHILLS (Chills), MYALGIA (Body aches) and PYREXIA (Fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, SARS-CoV-2 test: negative (Negative) Negative.         Concomitant product also included One A Day Multivitamin for an unknown indication.  Treatment products also included steroids and Sinus Cocktails.   This case was linked to MOD-2021-211523 (Patient Link).
baby was given the DTaP + Hep B Vaccine.  lethargic (slept a lot more than usual) and body temperature got to 99.8. These symptoms persisted Monday evening and Tuesday.  Seemed to "come out of it" on Wednesday.
Paleness, Sweating, Nausea, Dizziness, Weakness Immediately following injection.
Itching at injection site and around, redness and hot to touch, 3-4 in redness around injection site, soreness for first few day after injection
Fatigue, muscle aches, bone pain, headache for 2 consecutive  days (7/10 and 7/11) after COVID shot. Symptoms resolved on 7/12 w/o intervention   On 7/14/21, new symptoms of chest pain and shortness of breath started.  Still experiencing chest pain and shortness of breath as of 7/17/2021.  I have not sought out any medical attention
Patient reported she had an episode of fainting after second Covid vaccine on her way to restroom the following day after receiving the vaccine. Patient not sure if vaccine related or not but reported doing fine with the first vaccine prior. No negative outcomes following fainting episode and patient reports she has been fine since.
Severe Pain in n left upper arm and shoulder, extreme tiredness,  sweating and freezing
Some 2 3/4 days later, I became somewhat dizzy. Not being able to walk straight (drifting to the left). A minute or so later I lost my balance, fell backward and landed on my butt (and some Hostas). I tried to get up but was very dizzy for a couple of minutes. I did not black out. My vision was fine. I was able to stand up and gingerly walked around. I have never had this problem and it has not reoccurred since.
In the middle of the night after receiving the booster shot I awoke with extreme chills and severe pain of the entire body. The morning after the booster shot (Thursday) I vomited two times and felt total exhaustion the entire day with the severe pain of the entire body continuing all day. I also felt confused all day and could barely move. On Friday I experienced diarrhea in addition to the extreme pain and confusion. On Saturday I slowly started to recover and on Sunday I was finally moving better. By Monday I felt back to normal. I reported the incident to my doctor on Thursday and came in for an office visit on Friday. I was told by my doctor that I received double the dose I should have received. I previously had received both Pfizer vaccines but my doctor gave me Moderna as my booster shot. Instead of giving the smaller dose the nurse gave me double the dose I was supposed to receive.
They noticed the vaccine card states they received another Moderna vaccine dose. they wonder if this may be harmful for their health if they may have had a overdose; This spontaneous case was reported by a consumer and describes the occurrence of OVERDOSE (They noticed the vaccine card states they received another Moderna vaccine dose. they wonder if this may be harmful for their health if they may have had a overdose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In March 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Nov-2021, the patient experienced OVERDOSE (They noticed the vaccine card states they received another Moderna vaccine dose. they wonder if this may be harmful for their health if they may have had a overdose). At the time of the report, OVERDOSE (They noticed the vaccine card states they received another Moderna vaccine dose. they wonder if this may be harmful for their health if they may have had a overdose) outcome was unknown.            No concomitant medications were provided.  No treatment medications were provided.
EMPLOYEE STATED FEELING LIGHT HEADED, DIZZY, HEADACHE, AND NAUSEA ABOUT 5 MIN AFTER VACCINATION. EMPLOYEE CONTINUES TO HAVE "WAVES OF DIZZINESS, LIGHT HEADED AND NAUSEA. TEMP AT TIME OF SYMPTOMS 98.1, BP132/84, P82.
fatigue onset 24hr p/vax, lasted all day;h/a onset 12hr p/vax, lasted 24hr; nausea onset 24hr p/vax, lasted all day;
Itchy red bumps of varying size started on left arm and over the course of a week continue to other areas including right arm, neck, head.  Almost like blisters, any itching causes them to break open and bleed.  The seem to be subsiding finally (after 2 weeks) but some new small ones still seem to be popping up.  I can't seem to match up with anything else by viewing photos online, looks most similar to scavies, but nothing else fits (hasn't spread to family members, location on my body etc...)  I was working in a wooded area the weekend prior to vaccination but the bumps don't match anything I can find for plant based rash. Tried to seek medical help, but appointments are all booked and cannot get an expedient visit.  I haven't considered it concerning enough for an ER visit.
Sudden back pain radiating to the legs, patient was asked if she needed us to call the Ambulance and she said yes, patient felt better and she did not need to be transported to the hospital and walked to her car, she is expected to be seen by a local doctor at urgent care center.
Developed shingles in left eye and on left forehead. Was on antivirals for 30 days. Saw primary care doctor and two different eye doctors over 8 appointments between Mon 3/22/2021 and Fri 5/14-2021.
pt stated she woke up next morning after vax and could not breath, vomiting, could not feel spine, ribs or entire left arm.  pt states she has recovered from all of these symptoms with the exception of breathing properly.  Pt says she still has shortness of breath.  Pt went to her PCP but was not given any medication since they were not sure how to treat her condition in which they told her to contact VAERS.
pt c/o myalgias, h/a, neck stiffness persisting for 1wk p/vax;also had tenderness of glands but only minimally enlarged anterior cervical nodes;
Flu like symptoms including: body/muscle aches, sharp headaches, fatigue and feeling winded, chills and sweats, loss of appetite, pain at injection site and shoulder. It has been 46 since receiving the booster. Still experiencing symptoms.  Treatment includes water and ibuprofen.
Booster dose administered prior to the recommended interval. Primary series received on 5/26/2021 and 11/17/2021. No adverse effect noted.
2 days after vaccination patient experienced nausea and developed flu like symptoms. Nausea began to subside 4 days later. She never vomited, but still has no appetite. Her naturopath told her vaccine is live and toxic, and her immune system can't fight it. Patient's MD told her it is not a live vaccine. She doesn't believe him due to statement by naturopath.
arm very swollen and red; arm very swollen and red; This is a spontaneous report from contactable nurse via Pfizer Sales Representative. This nurse reported events for three patients. This is the second of 3 reports.    An 18-year-old female patient receive the 2nd dose of meningococcal group b rlp2086 (TRUMENBA) (lot # CM1497), via an unspecified route of administration at single dose in the arm on 07Jul2020 for immunisation. The patient medical history and concomitant medications were not reported.   On 07Jul2020, the patient experienced arm very swollen and red with outcome of recovering. Therapeutic measures were taken as a result of arm very swollen and red included to apply ice and take Motrin.  No follow-up attempts are needed. No further information is expected.
Presented for cough, SOB. Dx w/COVID 6 days prior. Hx HTN. Did not require much O2, CXR normal. Tx with O2 2L NC, abx, steroid, Vit C, zinc. DCd home.
Administrator inserted the needle, I believe hit my bone, and stated that they couldn't inject. I told them to pull the needle back a little. Once they did that, the vaccine was able to be injected. I had pain and tenderness immediately and since then, have been unable to sleep on my right arm due to nightly numbness and tingling at night. During the day, I have tenderness and soreness on that right arm
No other AE details available at this time; Caller reported temperature excursion. / Temperature -1 3.3C; This spontaneous report was received from a registered nurse concerning to a 4-year-old patient of unknown gender. The patient's medical history, historical drugs, allergies, concurrent conditions and concomitant therapies were not provided.  On 24-DEC-2020, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD), 0.5 milliliter (ml) for prophylaxis, lot number reported as T021638 and expiration date reported as 21-FEB-2021, but upon internal validation established as 21-DEC-2021 (vaccination scheme, route of administration and anatomical site of vaccination were not provided). No additional adverse events were reported.  The administered vaccine had a temperature excursion of -13.3 degrees Celsius (°C) for a time frame of 4 hours and 15 minutes on an unspecified date, and the data was recorded by a digital data logger. It was also reported there was not a previous temperature excursion.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2012USA013095: US-009507513-2012USA013596: US-009507513-2012USA013584: US-009507513-2012USA013095:
Patient received routine WBC, EPS, DT with immunizations on 01/03/2007. Dad called01/05/2007 stated patient was sleeping more and not taking formula well. Patient seen in our office and gained 5 oz and well hydrated inflammation at site of Prevnar injection.
pt recv vax; swelling, both hands and c/o pain to both wrists; pt previously seen in er;
This spontaneous report as received from a physician assistant refers to a female "teenager" patient of unknown age. The patient was vaccinated with the second dose of GARDASIL (lot # unspecified) 0.5 ml on 21-JAN-2013. It was not unknown when the first dose of GARDASIL was given. No other co-suspects were reported. Concomitant medications included: influenza virus vaccine (manufacturer unspecified). On 21-JAN-2013, as the patient was walking towards the exit, she fainted, falling on the ground and hurting her neck. The patient was allowed to rest at the office, and by the time the patient left the office later that day, she was "fine". The doctor did not specify if the patient still had neck pain or not. No treatment information was given. The patient had sought medical attention. Additional information is not expected.
4/20/21 swelling of all finger tips and pain. Unable to touch or grip objects. Took ibuprofen and it didn't help. Ice bath eased pain for 5-10 minutes.
Rash noted on face, arms and legs.  Slightly raised area on L arm where Varicella was given.
arthritis; This is a spontaneous report from a Pfizer sponsored program regulatory authority. A contactable male consumer (husband) reported for a female patient (reporter's wife). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: not reported, Expiry date: not reported), dose 1 via an unspecified route of administration on 16Mar2021 as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced arthritis on an unspecified date. The outcome of event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
High temperature; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (High temperature) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (High temperature). At the time of the report, PYREXIA (High temperature) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: high (High) High.         No concomitant products were reported.  No treatment information was provided.